|
KLHL12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.3149000002235E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72505999999073E-05 |
| Normal-vs-Stage2 |
6.202200E-03 |
| Normal-vs-Stage3 |
6.02889999999912E-05 |
| Normal-vs-Stage4 |
1.856770E-03 |
| Stage1-vs-Stage2 |
5.696800E-01 |
| Stage1-vs-Stage3 |
8.572200E-01 |
| Stage1-vs-Stage4 |
7.541000E-01 |
| Stage2-vs-Stage3 |
6.863800E-01 |
| Stage2-vs-Stage4 |
8.466000E-01 |
| Stage3-vs-Stage4 |
8.675600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.20379999996234E-06 |
| Normal-vs-AfricanAmerican |
1.631400E-01 |
| Normal-vs-Asian |
5.844200E-03 |
| Caucasian-vs-AfricanAmerican |
8.003700E-02 |
| Caucasian-vs-Asian |
3.137200E-01 |
| AfricanAmerican-vs-Asian |
3.942000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64738999999248E-05 |
| Normal-vs-Female |
2.08599999999004E-05 |
| Male-vs-Female |
5.256600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.10990000004685E-06 |
| Normal-vs-Age(41-60Yrs) |
4.81429999998895E-06 |
| Normal-vs-Age(61-80Yrs) |
1.499340E-03 |
| Normal-vs-Age(81-100Yrs) |
3.735700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.753600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.532400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.681600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.153400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.251000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.744200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.323600E-01 |
| Classical-VS-Follicular |
7.124800E-01 |
| Classical-VS-Other |
3.375200E-01 |
| Classical-VS-Normal |
1.002250E-04 |
| Tall-VS-Follicular |
8.394200E-01 |
| Tall-VS-Other |
4.225400E-01 |
| Tall-VS-Normal |
5.990300E-04 |
| Follicular-VS-Other |
4.927600E-01 |
| Follicular-VS-Normal |
3.765800E-04 |
| Other-VS-Normal |
7.321100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.85979999997888E-06 |
| Normal-vs-N1 |
1.52352999999161E-05 |
| N0-vs-N1 |
2.818000E-01 |
|
|
